Eyenovia Inc.

09/05/2024 | Press release | Distributed by Public on 09/05/2024 05:48

Eyenovia Announces Taiwan Export License Approval to Commence Shipment of Clobetasol Propionate Ophthalmic Suspension (0.05%) to the U.S.

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.